Effect of SMART DNA Therapy Retix.C Application on Skin Microbiome

Background: The skin microbiome plays a key role in maintaining skin health, and its composition can be influenced by cosmetic treatments. This study aimed to investigate the effects of SMART DNA Therapy treatment on facial skin microbiome composition, with specific focus on changes in commensal and pathogenic bacterial populations following multi-component anti-aging intervention. Methods: This clinical study included 10 Caucasian female participants aged 28–50 years (Clinical trial registration number: 0406/2023). Each participant received three Retix.C SMART DNA THERAPY treatments at 14-day intervals over 6 weeks. The protocol included three phases: chemical peeling with ferulic acid, peptide microinjections for DNA repair, and home-care products with antioxidants. Bacterial samples were collected from forehead and cheek skin before treatment and 2 weeks after the final treatment. Samples were analyzed using bacterial culture and PCR methods. Results: After treatment, the skin microbiome showed beneficial changes with increased numbers of helpful bacteria and elimination of harmful bacteria: complete removal of Cutibacterium acnes and Staphylococcus aureus was observed, Staphylococcus epidermidis and other beneficial bacteria increased on both forehead and cheek areas. Overall bacterial diversity decreased, and participants exhibited more similar microbiome patterns after treatment. Conclusions: SMART DNA Therapy treatment successfully modified the skin microbiome by increasing protective bacteria and eliminating pathogenic species. The treatment may support skin health through microbiome modulation and the potential antioxidant effects of its active ingredients, although these were not directly assessed in this study.